Umeå Economic Studies |
|
Abstract: This paper analyses how market shares for brand name drugs are affected by generic competition. The analysis is based on micro data for twelve original drugs, wich are all subject to generic competition. For five of these drugs, we find that the price of the original relative to the average price of the generic substitutes significantly affects the market share of the original. In addition, the introduction of a so called "reference price" system appears to have had a significant impact on the market share of five original drugs.
Keywords:Pharmeceutical industry, Patent expiration, micro data.
JEL-Codes:L65,I11
21 pages, 1998
Before downloading any of the electronic versions below
you should read the following statement on
copyright.
Download GhostScript
for viewing Postscript files and the
Acrobat Reader for viewing and printing pdf files.
Full text versions of the paper:
ues462.ps PostScript file (2 383 kB) ues462.ps.zip PKZipped PostScript file (361 kB) ues462.pdf Adobe Acrobat pdf file (214 kB) ues462.pdf.zip PKZipped Acrobat pdf file (126 kB)